BCC Research reveals in its new report, OTC Drugs, Medical Devices, and Diagnostics: Global Markets, the over-the-counter ...

Kenvue Inc. closed 6.21% short of its 52-week high of $24.46, which the company reached on November 26th.

Kenvue Inc. closed 5.19% short of its 52-week high of $24.46, which the company achieved on November 26th.

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and professionals to foster the management of minor ailments in China over the ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

📅 Voted Product of the Year Singapore 2025 winners are out! 100% consumer-voted, recognizing the most trusted and innovative products this year. Melissa Cornette POY SEA ... Visit us on social media: ...

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and professionals to foster the management of minor ailments in China over the ...

In the latest quarter, 11 analysts provided ratings for Kenvue (NYSE:KVUE), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

Redburn Atlantic initiated coverage of Kenvue (KVUE) with a Neutral rating and $23.50 price target The company’s first two years as a public ...

Highlights,Institutional shareholding in Kenvue Inc.,(NYSE:KVUE),reflects recent structural adjustments.,Several firms modified allocations within the consumer health space.,Ownership patterns suggest ...